Stocks and Investing
by (remove) : Leah Cann
RSS • JSON • XML • CSV
Stocks and Investing
by (remove) : Leah Cann
RSS • JSON • XML • CSV
Thu, June 24, 2021
[ Thu, Jun 24th 2021 ] - WOPRAI
Leah Cann Initiated (CCCC) at Strong Buy and Held Target at $54 on, Jun 24th, 2021
Wed, February 20, 2019
[ Wed, Feb 20th 2019 ] - WOPRAI
Leah Cann Initiated (AGIO) at Hold on, Feb 20th, 2019
Thu, April 13, 2017
[ Thu, Apr 13th 2017 ] - WOPRAI
Leah Cann Initiated (VSTM) at Buy and Held Target at $72 on, Apr 13th, 2017
Tue, January 17, 2017
[ Tue, Jan 17th 2017 ] - WOPRAI
Leah Cann Upgraded (AGIO) to Buy on, Jan 17th, 2017
Tue, November 29, 2016
[ Tue, Nov 29th 2016 ] - WOPRAI
Leah Cann Initiated (AGIO) at Hold on, Nov 29th, 2016
Mon, April 27, 2015
[ Mon, Apr 27th 2015 ] - WOPRAI
Leah Cann Initiated (VSTM) at Hold on, Apr 27th, 2015
Tue, April 21, 2015
[ Tue, Apr 21st 2015 ] - WOPRAI
Leah Cann Initiated (AGIO) at Hold on, Apr 21st, 2015
Tue, July 8, 2014
[ Tue, Jul 08th 2014 ] - WOPRAI
Leah Cann Initiated (VSTM) at Hold and Held Target at $108 on, Jul 8th, 2014

Leah Cann Initiated (CCCC) at Strong Buy and Held Target at $54 on, Jun 24th, 2021


Published on 2024-10-27 17:03:09 - WOPRAI, Leah Cann
  Print publication without navigation


Leah Cann of Brookline Capital, Initiated "C4 Therapeutics, Inc." (CCCC) at Strong Buy and Held Target at $54 on, Jun 24th, 2021.

Leah has made no other calls on CCCC in the last 4 months.



There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 0 agree with Leah's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Leah

  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $63 on, Friday, June 4th, 2021
  • Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $55 on, Wednesday, March 31st, 2021
Contributing Sources